Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Pediatric infectious disease chief authors new vaccination guideline for immunocompromised patients

05.12.2013
A new guideline released Thursday by the Infectious Diseases Society of America (IDSA) notes that most people with compromised immune systems are especially vulnerable to illness and should receive the flu shot and other vaccinations.

The guideline, entitled "Clinical Practice Guideline for the Vaccination of the Immunocompromised Host," was authored by Lorry G. Rubin, MD, director of the pediatric infectious diseases at Cohen Children's Medical Center of New York in New Hyde Park, NY, and professor of pediatrics at the Hofstra North Shore-LIJ School of Medicine, and will be published online Thursday in Clinical Infectious Diseases.

The new guideline aims to aid primary care physicians and specialists who treat immunocompromised patients (people with compromised immune systems, such as those with cancer, HIV infection and Crohn's disease), and those who live with immunocompromised patients.

"The guideline provides 'one-stop shopping' for clinicians caring for children and adults with compromised immune systems and includes recommendations and evidence for all vaccinations, from influenza to chicken pox," said Dr. Rubin. "Previously, the recommendations were difficult to retrieve because in most cases information had to be accessed individually by vaccine rather than by the category of patient disease."

The new guideline includes recommendations for most available vaccinations, ranging from hepatitis A, measles, mumps and rubella and other childhood vaccinations to those for influenza, pneumococcus and herpes zoster. It applies to patients with congenital immune deficiencies, HIV/AIDS, cancer, solid organ transplant (such as kidney and liver), stem cell transplant, chronic inflammatory conditions (such as rheumatoid arthritis and Crohn's disease), sickle cell disease and asplenia, cochlear implants, and cerebrospinal fluid (CSF) leaks. The guideline notes that most immunocompromised patients six months or older should receive the annual influenza shot, but should not receive the live attenuated influenza vaccine that comes in the form of a nasal spray. Patients receiving intensive chemotherapy or who have received anti-B-cell antibodies in the previous six months are unlikley to benefit from a flu shot.

The panel that developed the guideline includes adult and pediatric specialists in gastroenterology, immunology, infectious diseases, hematology, oncology, rheumatology and stem-cell and solid-organ transplantation. In addition to Dr. Rubin, the panel includes: Myron J. Levin, MD, Per Ljungman, MD, PhD, E. Graham Davies, MD, Robin Avery, MD, Marcie Tomblyn, MD, Athos Bousvaros, MD, Shireesha Dhanireddy, MD, Lillian Sung, MD, PhD, Harry Keyserling, MD, and Insoo Kang, MD.

The vaccination of immunocompromised patient guideline will be available in mobile device, pocket-sized quick-reference editions, and on the IDSA website http://www.idsociety.org.

About Cohen Children's Medical Center of New York

Opened in 1983, Cohen Children's Medical Center of New York is home to about 675 pediatricians, including 170 full-time physicians, and a total workforce of more than 1,200, including more than 500 nurses. For the seventh consecutive year in 2013, Cohen was ranked among the best children's hospitals in the nation in U.S. News & World Report's 2013-14 "America's Best Children's Hospitals" survey.

Emily Ng | EurekAlert!
Further information:
http://www.nshs.edu
http://www.idsociety.org

More articles from Health and Medicine:

nachricht Cholesterol-lowering drugs may fight infectious disease
22.08.2017 | Duke University

nachricht Once invincible superbug squashed by 'superteam' of antibiotics
22.08.2017 | University at Buffalo

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

Cholesterol-lowering drugs may fight infectious disease

22.08.2017 | Health and Medicine

Meter-sized single-crystal graphene growth becomes possible

22.08.2017 | Materials Sciences

Repairing damaged hearts with self-healing heart cells

22.08.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>